Michel Orsinger

About

Michel Orsinger is the Chairman of AO Invest and has held various global leadership positions in the Consumer and Healthcare/Med Tech industries—including Novartis (Divisional President), Synthes (CEO & President) and Johnson & Johnson (Worldwide Executive Chairman Global Orthopedics DePuy Synthes). Orsinger is now an investor, board member of various start-ups, advisor to a Private Equity company and Member of the Board of Takeda. Orsinger studied at the University of St. Gallen and attended management programs at Harvard Business School and INSEAD.

Investment Focus